<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.2" xml:lang="ru" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="issn">2658-6533</journal-id><journal-title-group><journal-title>Research Results in Biomedicine</journal-title></journal-title-group><issn pub-type="epub">2658-6533</issn></journal-meta><article-meta><article-id pub-id-type="doi">10.18413/2313-8955-2018-4-1-3-15</article-id><article-id pub-id-type="publisher-id">1371</article-id><article-categories><subj-group subj-group-type="heading"><subject>Medicine (miscellaneous)</subject></subj-group></article-categories><title-group><article-title>DIAGNOSTIC POSSIBILITIES OF DIFFERENT METHODS OF INVESTIGATION (LUMBAR PUNCTURE, NEUROIMAGING) IN ACUTE LYMPHOBLASTIC  LEUKEMIA AND NEUROLEUKEMIA IN CHILDREN</article-title><trans-title-group xml:lang="en"><trans-title>DIAGNOSTIC POSSIBILITIES OF DIFFERENT METHODS OF INVESTIGATION (LUMBAR PUNCTURE, NEUROIMAGING) IN ACUTE LYMPHOBLASTIC  LEUKEMIA AND NEUROLEUKEMIA IN CHILDREN</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Dzhanybekova</surname><given-names>Indira A.</given-names></name><name xml:lang="en"><surname>Dzhanybekova</surname><given-names>Indira A.</given-names></name></name-alternatives><email>indirad8@mail.ru</email></contrib></contrib-group><pub-date pub-type="epub"><year>2018</year></pub-date><volume>4</volume><issue>1</issue><fpage>0</fpage><lpage>0</lpage><self-uri content-type="pdf" xlink:href="/media/medicine/2018/1/1._Джаныбекова_И.А..pdf" /><abstract xml:lang="ru"><p>Modern methods of investigation of the central nervous system &amp;ndash; computerized tomography, magnetic-resonance imaging tomography &amp;ndash; have good diagnostic value, especially for revealing brain tumors. However, a high proportion of false results (30-58%) in acute lymphoblastic leukemia (ALL), neuroleukemia (NL) does not allow to focus on modern instrumental neuroimaging (NV). Therefore, the old routine method of NL diagnostics &amp;ndash; lumbar puncture &amp;ndash; is acquiring a new modern practical value, because diagnostics of NL is necessary in the early stages of treatment, during the 1st week of induction therapy, for revealing such an important risk factor as initial NL and for determining an appropriate approach in the volume of high-dosage therapy. Early diagnostics of initial NL determine the indications for cranial irradiation and rate of radial exposition. Timely selected tactics and strategy for treating ALL and INL contribute to the increase in survival and recovery of ill children. Therefore, lumbar puncture continues to be the only diagnostic and treatment method for ALL and NL. Therefore, the biomarker panel of the CSF can be useful in the treatment of ALL and NL. The most commonly used methods of neuroimaging include: MRI, CT with contrast, MR spectroscopy, diffuse-tensor MRI, phlebography. The CSF method used in the study was equivalent to radioactive isotopes and neurospecific proteins of CSF. The studied indicators (concentration of total protein, albumin, globulins, &amp;alpha;-amino nitrogen, neuroactive amino acids &amp;ndash; glutamic acid, glutamine concentrations) in CSF and blood serum in ALL (status CNS-1) were the following: acute period, remission, bone marrow relapse and developed NL: preclinical and clinical variants of NL (CNS-3), initial NL in children (CNS-6). Concentration gradients of CSF/ serum for albumin, amino nitrogen, glutamic acid, glutamine in various periods of ALL and NL, and in the complication of NL (ST-CNS-3, -6) in children were determined. Cytosis was not always consistent with the clinical presentation. Protocol therapy showed the best survival results. CSF was scanned quickly, the incidence of NL was only 2,4%, as in the original German protocols. 3-component intrathecal therapy (TIT), increased in acute period, and consolidation had better outcomes. The study of the permeability coefficients of the blood-brain barrier in ALL and NL in children demonstrated their prognostic significance (remission, prolonged course, lethal outcome).</p></abstract><trans-abstract xml:lang="en"><p>Modern methods of investigation of the central nervous system &amp;ndash; computerized tomography, magnetic-resonance imaging tomography &amp;ndash; have good diagnostic value, especially for revealing brain tumors. However, a high proportion of false results (30-58%) in acute lymphoblastic leukemia (ALL), neuroleukemia (NL) does not allow to focus on modern instrumental neuroimaging (NV). Therefore, the old routine method of NL diagnostics &amp;ndash; lumbar puncture &amp;ndash; is acquiring a new modern practical value, because diagnostics of NL is necessary in the early stages of treatment, during the 1st week of induction therapy, for revealing such an important risk factor as initial NL and for determining an appropriate approach in the volume of high-dosage therapy. Early diagnostics of initial NL determine the indications for cranial irradiation and rate of radial exposition. Timely selected tactics and strategy for treating ALL and INL contribute to the increase in survival and recovery of ill children. Therefore, lumbar puncture continues to be the only diagnostic and treatment method for ALL and NL. Therefore, the biomarker panel of the CSF can be useful in the treatment of ALL and NL. The most commonly used methods of neuroimaging include: MRI, CT with contrast, MR spectroscopy, diffuse-tensor MRI, phlebography. The CSF method used in the study was equivalent to radioactive isotopes and neurospecific proteins of CSF. The studied indicators (concentration of total protein, albumin, globulins, &amp;alpha;-amino nitrogen, neuroactive amino acids &amp;ndash; glutamic acid, glutamine concentrations) in CSF and blood serum in ALL (status CNS-1) were the following: acute period, remission, bone marrow relapse and developed NL: preclinical and clinical variants of NL (CNS-3), initial NL in children (CNS-6). Concentration gradients of CSF/ serum for albumin, amino nitrogen, glutamic acid, glutamine in various periods of ALL and NL, and in the complication of NL (ST-CNS-3, -6) in children were determined. Cytosis was not always consistent with the clinical presentation. Protocol therapy showed the best survival results. CSF was scanned quickly, the incidence of NL was only 2,4%, as in the original German protocols. 3-component intrathecal therapy (TIT), increased in acute period, and consolidation had better outcomes. The study of the permeability coefficients of the blood-brain barrier in ALL and NL in children demonstrated their prognostic significance (remission, prolonged course, lethal outcome).</p></trans-abstract><kwd-group xml:lang="ru"><kwd>lumbar puncture</kwd><kwd>neuroimaging</kwd><kwd>blood-brain barrier</kwd><kwd>cerebrospinal fluid</kwd><kwd>acute lymphoblastic leukemia</kwd><kwd>neuroleukemia</kwd><kwd>children</kwd></kwd-group><kwd-group xml:lang="en"><kwd>lumbar puncture</kwd><kwd>neuroimaging</kwd><kwd>blood-brain barrier</kwd><kwd>cerebrospinal fluid</kwd><kwd>acute lymphoblastic leukemia</kwd><kwd>neuroleukemia</kwd><kwd>children</kwd></kwd-group></article-meta></front><back><ref-list><title>Список литературы</title><ref id="B1"><mixed-citation>Vilchevskaya, E.V. (2002), &amp;ldquo;Pozdniye oslozhneniya profilaktiki neyroleykemii u detey s ostrym limfoblastnym leykozom&amp;rdquo; [Late complications of prevention of neuroleukaemia in children with acute lymphoblastic leucosis], Ukr. Jurnal hematoltransfuz, 4, 25-29. Russian.</mixed-citation></ref><ref id="B2"><mixed-citation>Lushnikov, E.F. (2006), &amp;ldquo;20-let morfologicheskikh issledovaniy meditsinskikh posledstviy Chernobyl&amp;#39;skoy avarii&amp;rdquo; [20-years of morphological research of medical consequences of Chernobyl accident], Archiv patologii, 2 (68), 3-7. Russian.</mixed-citation></ref><ref id="B3"><mixed-citation>Rogacheva, E.R. (2007), Optimizatsiya TSNS-napravlennoy terapii v programmnom lechenii ostrogo limfoblastnogo leykoza u detey. M. [Optimization of CNS-target therapy in acute lymphoblastic leukemia in children] Abstract of doctoral thesis in med. sciences. Moscow, 44. Russian.</mixed-citation></ref><ref id="B4"><mixed-citation>Rumyantsev, A.G. (2015), &amp;ldquo;Evolyutsiya lecheniya ostrogo limfoblastnogo leykoza u detey: empiricheskiye, biologicheskiye i organizatsionnyye aspekty&amp;rdquo; [Evolution of treatment of acute lymphoblastic leukemia in children; empiric, biological and organization aspects], Voprosi gematologii/oncologii i immunologii v pediatrii, 2, 5-15. Russian.</mixed-citation></ref><ref id="B5"><mixed-citation>Rumyantseva, J.V. (2011), Risk-adaptirovannaya terapiya ostrogo limfoblastnogo leykoza u detey i podrostkov v issledovanii ALL-MV-2002: Abstract of PhD thesis in med. sciences. M.; [Risk-adapting therapy of acute lymphoblastic leukemia in children and teenagers in research ALL-МВ-2002]. Abstract of doctoral thesis in med. sciences. Moscow, 44. Russian.</mixed-citation></ref><ref id="B6"><mixed-citation>Shugareva, L.M., Boichenko, A.G. (2012), &amp;ldquo;Nevrologicheskiye oslozhneniya u detey s ostrym limfoblastnym leykozom&amp;rdquo; [Neurologic complications in children with acute lymphoblastic leukemia], Zhurnal nevropatologii i psikhiatrii im. S.S. Korsakova. 2 (112), 80-84. Russian.</mixed-citation></ref><ref id="B7"><mixed-citation>Asami, T., Tanaka, A., Asami, K., Sakai, K. (1986), &amp;ldquo;Use of cerebrospinal fluid sialic acid to diagnose and monitor CNS leukemia&amp;rdquo;, Acta med. etbiol, 34 (3), 85-92.</mixed-citation></ref><ref id="B8"><mixed-citation>Chamberlain, M.C. (2008), &amp;ldquo;Leukemia and the nervous system.Medicine Current Oncology Reports&amp;rdquo;, Cancer Neurology In Clinical Practice, 7, 555-565.</mixed-citation></ref><ref id="B9"><mixed-citation>Ficek, K., Blamek, S., Sygula, D., Miszczyk, L., Santa-Jakimczyk, D., Tarnawski, R. (2010), &amp;ldquo;Evaluation of the late effects of CNS prophylactic treatment in childhood acute lymphoblastic leukemia (ALL) using magnetic resonance spectroscopy&amp;rdquo;, Acta Neurochir,</mixed-citation></ref><ref id="B10"><mixed-citation>106, 195-197.</mixed-citation></ref><ref id="B11"><mixed-citation>Goldman, A., Hain, R., Liben, S. (2012), Oxford textbook of palliative care for children. 2nd edition. Oxford university press.</mixed-citation></ref><ref id="B12"><mixed-citation>Karachunsiy, A., Romiantseva, J., Lagoiko, S., Buhrer, C., Tallen, G., Aleinikova, O. (2015), &amp;ldquo;Efficacy and toxicity of dexamethasone vs methylprednisolone long-term results in more than 1000 patients from the Russian randomized multicentric trial ALL-MB-2002&amp;rdquo;, Leukemia, 10 (1038), 63-66.</mixed-citation></ref><ref id="B13"><mixed-citation>Laningham, F.H., Kun, L.E., Wilburn, R.E. (2007), &amp;ldquo;Childhood central nervous system leukemia: historical perspectives, current therapy, and acute neurological sequelae&amp;rdquo;, Neuroradiology, 49 (11), 873-888.</mixed-citation></ref><ref id="B14"><mixed-citation>Sandberg, D.I., Bilsky, M.H., Souweidane, M.M., Bzdil, J., Gutin, P.H. (2000), &amp;ldquo;Ommaya reservoirs for the treatment of leptomeningeal metastases&amp;rdquo;, Neurosurgery, 47 (1), 49-54.</mixed-citation></ref><ref id="B15"><mixed-citation>Shrappe, M. (2004), &amp;ldquo;Evolution of BFM trials for childhood acute lymphoblastic leukemia&amp;rdquo;, Ann.Hematol, 83 (1), 121-123.</mixed-citation></ref></ref-list></back></article>